Post Views: 4

Wie erkenne ich, ob eine Veränderung bösartig ist?

Clinical Triage Assessment

Case Summary
The patient presents with a new oral mucosal lesion of 2 weeks‘ duration. The lesion is reported to be increasing in size, painful, and bleeding. There is a significant history of tobacco (40 cigarettes/day) and alcohol consumption. The patient explicitly asks: „Ist es Krebs“ (Is it cancer). At this stage, a definitive diagnosis cannot be made, but the clinical presentation requires urgent investigation.

Extracted Variables
– new_lesion: yes
– malignancy_suspected: yes (due to red flag constellation and risk factors)
– cause_plausible: unknown
– residual_uncertainty: yes
– regression_after_2w: not assessable
– complete_regression_after_4w: not assessable
– brush_cytology_result: not performed
– histology_result: not performed

Red Flag Analysis
– Ulceration or erosion: not mentioned (not assessable)
– Red-white inhomogeneous character: not mentioned (not assessable)
– Pronounced hyperkeratosis: not mentioned (not assessable)
– Bleeding: present
– Conspicuous vascular pattern: not mentioned (not assessable)
– Exophytic / raised / mass-like: not mentioned (not assessable)
– Induration: not mentioned (not assessable)
– Progressive / duration unclear / new: present (new, increasing in size)
– No plausible cause: present (no cause identified in history)
– Conspicuous lymph nodes: not mentioned (not assessable)

Triage Level
Level A: „suspicion of malignancy / malignant lesion“.
Justification: The combination of a new, progressive lesion that bleeds, combined with a very high-risk profile (heavy smoking and alcohol consumption), creates a strong clinical suspicion of malignancy.

Next Step and Recommendation
Immediate referral to an oral and maxillofacial surgeon or a specialist for a diagnostic biopsy and comprehensive clinical evaluation. Timing: Immediately.

Follow-up Questions
1. Where exactly is the lesion located (e.g., tongue, floor of the mouth, cheek)?
2. Is the lesion palpable as a hard mass (induration)?
3. Are there any enlarged or painful lymph nodes in the neck area?
4. Is the surface of the lesion ulcerated (open sore)?
5. Have you noticed any numbness in the area or difficulty swallowing?

Dear Colleague,

Thank you for the referral of your patient. I have performed a structured risk assessment of the presented oral lesion following the S2k 007-092 algorithm and the institutional research index.

HISTORY

Reason for presentation: The patient presents with pain in the oral cavity.
First manifestation: The change was noticed by the patient personally.
Time course: The lesion has been present for 2 weeks and is reported to be increasing in size.
Current symptoms: The patient reports active pain.
Bleeding history: Contact or spontaneous bleeding is present.
Risk factors:
- Tobacco: 40 cigarettes per day. (Calculation: Assuming a typical 20-year smoking history for an adult, this would equal 40 pack-years).
- Alcohol: 4 beers daily.
- Betel quid / areca nut: Not reported.
- The combination of heavy tobacco use and regular alcohol consumption is an established synergistic risk factor for malignant transformation of oral mucosal lesions.
Aetiology: No obvious mechanical or iatrogenic cause was identifiable from the history.

ALGORITHMIC ASSESSMENT (S2k 007-092)

Red-flag screen: Positive. The patient exhibits „contact or spontaneous bleeding“ and „rapid progression“ (increasing size within 2 weeks).
Decision-tree walk-through:
1. New clinical change? $\rightarrow$ YES.
2. Clinical suspicion of malignancy? $\rightarrow$ YES (based on rapid progression and bleeding).
Terminal Node: Node B — BIOPSY.

AIDOCVISION RESEARCH INDEX (institutional, advisory, revised build)

Item	Value	Score
Q1 Reason for visit	Symptoms present	3
Q2 Detection	Self-noticed due to symptoms	3
Q3 Duration	2–3 weeks	2
Q4 Course	Rapid progression	5
Q5 Symptoms	Persistent pain	3
Q6 Bleeding	Spontaneous/Contact	5
Q7 Smoking	$>30$ pack-years (est.)	5
Q8 Alcohol	High chronic	5

Calculation:
$\text{AIDOCVISION-rev} = (1.5 \cdot 2 + 1.5 \cdot 5 + 1.2 \cdot 3 + 1.2 \cdot 5 + 0.8 \cdot 5 + 0.8 \cdot 5 + 0.5 \cdot 3 + 0.5 \cdot 3) / 8.0$
$\text{AIDOCVISION-rev} = (3 + 7.5 + 3.6 + 6 + 4 + 4 + 1.5 + 1.5) / 8.0 = 31.1 / 8.0 = \mathbf{3.88}$

Synergism Adjustment: Q7 $\ge$ 4 and Q8 $\ge$ 4 $\rightarrow$ +0.3
Final Index: $3.88 + 0.3 = \mathbf{4.18}$ $\rightarrow$ Band: Higher Concern

Disagreement Rule: The AIDOCVISION-rev band (Higher Concern) agrees with the 007-092 terminal node (Biopsy).

IMAGE vs. WORKING DIAGNOSIS

The image analysis confirms the presence of a suspicious lesion („Ja“). The clinical presentation of a rapidly growing, painful, and bleeding lesion in a patient with high-risk habits strongly correlates with the image findings.

DIFFERENTIAL DIAGNOSES

Squamous Cell Carcinoma (SCC): Most likely given the „red flags“ (bleeding, rapid growth), significant tobacco/alcohol synergy, and the patient’s specific question regarding malignancy.
Major Aphthous Ulcer / Deep Ulceration: Could present with pain and bleeding, though the rapid size increase and risk profile make this less likely than malignancy.
Traumatic Ulceration: While possible, the history does not mention a clear trigger, and the rate of progression is atypical for simple trauma.
Pyogenic Granuloma: Would explain the bleeding and rapid growth, but the associated pain and risk factors point more toward an epithelial malignancy.

Given the red-flag findings and the algorithmic path, a malignant or pre-malignant process cannot be excluded clinically and requires histopathological confirmation.

PLANNED MANAGEMENT

Following the terminal node (Node B) of the S2k 007-092 algorithm:

Incisional Biopsy: To be performed promptly. The specimen will be taken from the periphery/margin of the lesion to ensure the interface between healthy and diseased tissue is captured, avoiding necrotic central areas.
Histopathology dependent steps:
- If high-grade dysplasia, Carcinoma in situ, or SCC: Immediate referral to a specialized head and neck surgical center.
- If low-grade dysplasia: Close observation/control.
- If benign: Treat per cause and control until regression.
Counselling: The patient will be advised on the absolute necessity of smoking cessation and reduction of alcohol intake to improve prognosis and reduce further risk.

Safety-netting: The patient was instructed to re-present immediately if there is a further increase in lesion size, new/increased bleeding, progressive pain, new paraesthesia, or any difficulty swallowing (dysphagia).

Follow-up: Review scheduled immediately upon receipt of the pathology report (estimated 5–7 working days).

Sincerely,

Specialist in Oral & Maxillofacial Surgery

Clinical management governed by AWMF S2k-Guideline 007-092. AIDOCVISION is an institutional research index (revised build 01), not part of the guideline and not externally validated; research subject to change. Not a diagnosis. Clinical examination and histopathology are authoritative.
AIDOCVISION research build (rev 01) — DRAFT, not countersigned.

Termin vereinbaren

Ordination Dr. Michael Truppe
Albertgasse 3/6 1080 Wien

Telefon 01 408 95 00 66
Email ordination@smile.wien

Ein verbindlicher Behandlungsplan und Heilkostenplan wird gemäß den Vorgaben der Zahnärztekammer erst nach einer Konsultation in der Praxis erstellt.